AgeX Therapeutics Liabilities 2024

AgeX Therapeutics Aktienanalyse

What does AgeX Therapeutics do?

AgeX Therapeutics Inc is an emerging biopharmaceutical company focused on researching and developing innovative therapies to combat the aging process and related diseases. The company was founded in 2017 by Michael D. West, one of the most renowned pioneers in the field of regenerative medicine and stem cell research. AgeX Therapeutics' business model is based on utilizing groundbreaking knowledge in regenerative medicine, genomics, and cryobiology to develop new treatment methods that enable longer lifespan and higher quality of life. The company has developed a wide range of products and services focused on tissue and organ regeneration and repair. One of AgeX Therapeutics' main branches is the development of human embryonic stem cells (hES cells), which can be used as starting material for the production of cells and tissues. These cells have the potential to transform into any type of cell or tissue, making them a revolutionary tool in regenerative medicine. AgeX Therapeutics works closely with other companies and research institutions to further improve its hES cell technology and find new ways to implement it in practical applications. Another important area of AgeX Therapeutics is targeted genome editing, a procedure for modifying the genetic material of cells and organisms. This procedure can be used to correct genetic defects, treat diseases, or slow down the aging process. AgeX Therapeutics has developed its own technology platform to make targeted genome editing procedures more efficient and precise. AgeX Therapeutics' products and services also include bioelectric medicine, targeted senescence induction, and cryobiological storage. Bioelectric medicine utilizes electrical currents to promote tissue regeneration, while targeted senescence induction aims to selectively kill aging cells, thus slowing down the aging process. Cryobiological storage is a method for long-term storage of biological materials at extremely low temperatures to protect them from degradation and degeneration. AgeX Therapeutics is an ambitious company striving to expand the boundaries of regenerative medicine and discover new therapy options that improve people's quality of life. The company is financially stable and has a highly qualified team of scientists and medical professionals dedicated to achieving these goals. With its sophisticated technology platform and wide range of products and services, AgeX Therapeutics is well positioned to succeed in the rapidly growing market of regenerative medicine. AgeX Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing AgeX Therapeutics's Liabilities

AgeX Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating AgeX Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing AgeX Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

AgeX Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in AgeX Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about AgeX Therapeutics stock

What is the level of liabilities of AgeX Therapeutics this year?

AgeX Therapeutics has a debt balance of 6.5 M USD this year.

What were the liabilities of AgeX Therapeutics compared to the previous year?

The liabilities of AgeX Therapeutics have increased by -68.23% dropped compared to the previous year.

What are the consequences of high debt for investors of AgeX Therapeutics?

High liabilities can pose a risk for investors of AgeX Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in AgeX Therapeutics?

Low liabilities mean that AgeX Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of AgeX Therapeutics affect the company?

An increase in liabilities of AgeX Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of AgeX Therapeutics affect the company?

A decrease in the liabilities of AgeX Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of AgeX Therapeutics?

Some factors that can influence the liabilities of AgeX Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of AgeX Therapeutics so important for investors?

The liabilities of AgeX Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can AgeX Therapeutics take to modify the liabilities?

To change its liabilities, AgeX Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does AgeX Therapeutics pay?

Over the past 12 months, AgeX Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, AgeX Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of AgeX Therapeutics?

The current dividend yield of AgeX Therapeutics is .

When does AgeX Therapeutics pay dividends?

AgeX Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AgeX Therapeutics?

AgeX Therapeutics paid dividends every year for the past 0 years.

What is the dividend of AgeX Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is AgeX Therapeutics located?

AgeX Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von AgeX Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AgeX Therapeutics from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did AgeX Therapeutics pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of AgeX Therapeutics in the year 2023?

In the year 2023, AgeX Therapeutics distributed 0 USD as dividends.

In which currency does AgeX Therapeutics pay out the dividend?

The dividends of AgeX Therapeutics are distributed in USD.